Real-time automated assessment of histological disease activity in patients with ulcerative colitis using single-wavelength endoscopy technology

Abstract

Background

Single-wavelength endoscopy (SWE) has shown promising results in assessing histological disease activity in ulcerative colitis. Our objective was to validate the real-time performance of a bedside prototype of SWE computer-aided diagnosis (CAD) as proof of concept.

Methods

A bedside module for real-time use evaluated histological disease activity when endoscopy was performed in the rectum and sigmoid based on white-light endoscopy and SWE (410 nm monochromatic light). Biopsies were taken for reference and scored using the Geboes score (GBS). SWE-CAD displayed a blue or red indicator, corresponding to histological remission or non-remission, respectively. Simultaneous scoring using the Mayo Endoscopic Score was performed by the endoscopist.

Results

In 36 patients, histological disease activity was automatically scored using SWE-CAD. At the section level, SWE-CAD showed an accuracy of 96.4%, sensitivity of 96.1%, and specificity of 85.5%. When differentiating disease activity into mild, moderate, and severe, accuracy was 97.7%, 62.8%, and 95.0%, respectively. At the per-patient level, overall diagnostic accuracy remained high at 94.4%, with only 2/36 underestimations compared with GBS.

Conclusion

A novel SWE-CAD system demonstrated clinical accuracy of 94.4% at the per-patient level, potentially aiding physicians in interpreting subtle endoscopic abnormalities and paving the way to more individualized patient management.

• References

• 1 Papi C, Aratari A. Mucosal healing as a treatment for IBD?. Expert Rev Gastroenterol Hepatol 2014; 8: 457-459
• 2 Mazzuoli S, Guglielmi FW, Antonelli E. et al. Definition and evaluation of mucosal healing in clinical practice. Dig Liver Dis 2013; 45: 969-977
• 3 Ardizzone S, Cassinotti A, Duca P. et al. Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis. Clin Gastroenterol Hepatol 2011; 9: 483-489.e3
• 4 Pandey A, Achrafie L, Kodjamanova P. et al. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes. Curr Med Res Opin 2022; 38: 1531-1541
• 5 Lobatón T, Bessissow T, De Hertogh G. et al. The Modified Mayo Endoscopic Score (MMES): a new index for the assessment of extension and severity of endoscopic activity in ulcerative colitis patients. J Crohns Colitis 2015; 9: 846-852
• 6 Takenaka K, Ohtsuka K, Fujii T. et al. Deep neural network accurately predicts prognosis of ulcerative colitis using endoscopic images. Gastroenterology 2021; 160: 2175-2177.e3
• 7 Sinonquel P, Bossuyt P, Camps C. et al. An automated system for estimation of histological disease activity in ulcerative colitis: comparison of performances with white light versus single wavelength endoscopy. United European Gastroenterol J 2022; 10: 8
• 8 Bossuyt P, De Hertogh G, Eelbode T. et al. Computer-aided diagnosis with monochromatic light endoscopy for scoring histologic remission in ulcerative colitis. Gastroenterology 2021; 160: 23-25
• 9 Maeda Y, Kudo S, Mori Y. et al. Fully automated diagnostic system with artificial intelligence using endocytoscopy to identify the presence of histologic inflammation associated with ulcerative colitis (with video). Gastrointest Endosc 2019; 89: 408-415
• 10 Bossuyt P, Nakase H, Vermeire S. et al. Automatic, computer-aided determination of endoscopic and histological inflammation in patients with mild to moderate ulcerative colitis based on red density. Gut 2020; 69: 1778-1786
• 11 Sinonquel P, Bossuyt P, Sabino JPG. et al. Long-term follow-up of the red density pilot trial: a basis for long-term prediction of sustained clinical remission in ulcerative colitis?. Endosc Int Open 2023; 11: E880-E884
• 12 Iacucci M, Daperno M, Lazarev M. et al. Development and reliability of the new endoscopic virtual chromoendoscopy score: the PICaSSO (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis. Gastrointest Endosc 2017; 86: 1118-1127.e5
• 13 Gui X, Bazarova A, Del Amor R. et al. PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system. Gut 2022; 71: 889-898
• 14 Iacucci M, Smith SCL, Bazarova A. et al. An international multicenter real-life prospective study of electronic chromoendoscopy score PICaSSO in ulcerative colitis. Gastroenterology 2021; 160: 1558-1569.e8
• 15 Iacucci M, Cannatelli R, Parigi TL. et al. A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis. Endoscopy 2023; 55: 332-341
• 16 Colombel JF, D’Haens G, Lee WJ. et al. Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review. J Crohns Colitis 2020; 14: 254-266